Abdeldayem, T.; Jeyalan, V.; Hayat, A.; Memon, S.; Farag, M.; Egred, M.
Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety. J. Clin. Med. 2025, 14, 3956.
https://doi.org/10.3390/jcm14113956
AMA Style
Abdeldayem T, Jeyalan V, Hayat A, Memon S, Farag M, Egred M.
Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety. Journal of Clinical Medicine. 2025; 14(11):3956.
https://doi.org/10.3390/jcm14113956
Chicago/Turabian Style
Abdeldayem, Tarek, Visvesh Jeyalan, Afzal Hayat, Saif Memon, Mohamed Farag, and Mohaned Egred.
2025. "Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety" Journal of Clinical Medicine 14, no. 11: 3956.
https://doi.org/10.3390/jcm14113956
APA Style
Abdeldayem, T., Jeyalan, V., Hayat, A., Memon, S., Farag, M., & Egred, M.
(2025). Antithrombotic Therapy in Acute Coronary Syndrome Patients with End-Stage Renal Disease: Navigating Efficacy and Safety. Journal of Clinical Medicine, 14(11), 3956.
https://doi.org/10.3390/jcm14113956